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SUMMARY
The risk of acquiring Human Immunodeficiency
Virus (HIV)  infection following occupational
exposure to HIV- infected blood is low. It has
been considered that there is no risk of HIV
transmission where intact skin is exposed to HIV-
infected blood. However, health care workers
who are occupationally exposed to HIV infection
must have immediate access to post-exposure
prophylaxis (PEP). The risk of HIV transmission
through the route of injury sustained must be
assessed and adequate management given. Post-
exposure prophylaxis (PEP) should be
commenced within 1-2 hours of exposure and
should last one month for it to be effective. All
health care workers who report exposure to HIV
at work whether given PEP or not should be
followed up for six months before a negative
antibody test is used to reassure the individual
that infection has not occurred. The objective of
this article is to create awareness among health
care workers, particularly resident doctors, who
by  the nature of their work are exposed to
potentially  infected body fluids so that they can
present themselves rapidly for risk assessment
and commencement of ART if necessary in the
event of an occupational exposure to HIV.
INTRODUCTION
Human Immunodeficiency Virus (HIV) is the virus
that causes Acquired Immune Deficiency Syndrome
(AIDS). It can be transmitted from one person to
another through exposure to blood or body fluids
that contain the virus. Such fluids that contain the
virus include blood, semen, vaginal fluid, human
breast milk, amniotic fluid, cerebrospinal fluid,
pericardial fluid, peritoneal fluid, pleural fluid, synovial
fluid and exudative or other tissue fluid from burns
or skin lesions [1]. Other body fluid like sweat, tears,
saliva, urine and stool do not contain significant
quantities of HIV unless there is blood mixed with
them[1,2]. HIV is not transmitted through intact skin.
The principal risks of acquiring HIV infection are
through unprotected sexual contact, infant born to
an HIV infected woman, breast feeding and
percutaneous (through exposure of disrupted skin
to an infected person’s blood)[1].
In the work environment, health care
workers may be occupationally exposed to HIV
infection. Health care workers include all paid and
unpaid persons working in health care settings who
have the potential for exposure to infectious material,
for example blood, tissue, and specific body tissues
and medical supplies, equipment, or environ-mental
surfaces contaminated with these substances. Health
care workers include doctors, nurses,  pharmacists,
nursing assistants, emergency medical service
personnel,  therapists, students and trainees,
technicians and persons not directly involved in
patient care but potentially exposed to blood and
body fluids (e. g laboratory scientists and
technologists, clerical, housekeeping, maintenance
and volunteer personnel). The same principle of post-
exposure management could be applied to other
workers who have potential for occupational
exposure to blood and body fluids in other settings.
[1]
The risk of acquiring HIV infection following
occupational exposure to HIV infected blood is low.
Epidemiological studies have indicated that the
average risk for HIV infection after percutaneous
exposure to HIV infected blood in health care settings
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is about 0.3%. After a mucocutaneous exposure the
average risk is estimated at less than 0.1%. It has
been considered that there is no risk of HIV
transmission where intact skin is exposed to HIV-
infected blood [2]. Four factors are associated with
increased risk of occupationally acquired HIV
infection:
• Deep injury
• Visible blood on the device which caused
the injury
• Injury with a needle which had been placed
in a source patient’s blood vessel
• Terminal HIV- related illness in the source
patient.
It is estimated that the risk of HIV transmission after
percutaneous exposure involving larger volumes of
blood, particularly,  if the source patient‘s viral load
is  high, exceeds the average risk of 0.3%[2, 3].
It has been shown that immediate
administration of antiretroviral drugs may prevent
infection from occurring. Studies in health care
workers who have had needle stick exposures have
shown that post‘- exposure treatment with
antiretroviral drugs  can reduce the risk by 79%[4].
Risk Assessment and Management
There are three types of exposure in health care
settings associated with significant risk. These are:
• Percutaneous injury (from needles,
instruments, bone fragments, significant bites
which break the skin, and so on);
• Exposure of broken skin (abrasions, cuts,
eczema and so on)
• Exposure of mucous membranes including
the eye.
The Risk Is Assessed As Follows:
Negligible Risk: for example intact skin visibly
contaminated with blood or body fluids; kissing,
casual touching.
Management: reassurance and discharge
Low Risk: solid needle, superficial exposure on
intact skin Small volume (drops of blood) on mucous
membrane or non-intact skin exposures.Source is
asymptomatic or viral load <1500copies/ml
Management: counsel patient about risk of HIV,
HBV and HCV transmission
Discuss risk of HIV post-exposure prophylaxis- if
risk outweighs potential benefits, PEP not
recommended.
Moderate Risk: for example skin-penetrating
needle contaminated with blood or body fluid; wound
causing bleeding and produced by sharp instrument
visibly contaminated with blood.
Management: counsel patient about risk of HIV,
HBV and HCV transmission
Discuss risk of HIV post-exposure prophylaxis.
Accelerated HBV immunization or booster if already
immunized. Give 2-drug combination if required.
High Risk: large bore needle, deep injury, and
visible blood on device, needle in patient’s artery/
vein. Source known to be HIV, HBV or HCV
infected. Large volume (major blood splash on
mucous membrane or non-intact skin exposures)
Source patient is symptomatic, acute
seroconversion, high viral load.
Management: counsel patient about risk of HIV,
HBV and HCV transmission. Discuss risk of HIV
post-exposure prophylaxis. Accelerated HBV
immunization or booster if already immunized.
Consider HBV Immunoglobulin if source is a highly
infectious HBV carrier and patient is susceptible.
PEP definitely indicated. Give 3-drug combination
therapy. This regimen needs to be modified if index
case is likely to harbour drug resistant virus [3, 8].
Table 1 illustrates the schedule of investigations
recommended following exposure.
HIV Post-Exposure Antiretroviral Drug
Therapy
PEP should be commenced within 1-2 hours
of exposure and should last one month for it to be
effective. At least 6 months should elapse after
cessation of PEP before a negative antibody test is
used to reassure the individual that infection has not
occurred. Following any occupational exposure to
HIV, whether or not PEP was prescribed, health
care worker should attend occupational health follow
up for 6 months and be prepared to report symptom
of concern at any time. [3, 10]
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HIV Occupational Exposure
The following types of exposure to HIV infected
materials should be considered for post- exposure
prophylaxis:
• Needle-stick injury or injury with a sharp
object that has been used on a HIV positive
patient.
• Mucosal exposure of the mouth or eye by
splashing fluids
• Intact skin exposed to a large volume of
blood or potentially infectious secretions
• Broken skin exposed to a small volume of
blood or secretions. [5]
     Recommended 2-drug combination:
• Zidovudine (ZDV) 300mg twice daily
+lamivudine (3TC) 150mg twice daily
• Stavudine d4T 40mg twice daily +lamivudine
(3TC) 150mg twice daily
• Stavudine (d4T) 40mg twice daily
+didanosine (ddI) 400mg once daily
Recommended 3- drug combination:
Any of the 2-drug combination and Efavirenz
(EFV). Efavirenz is not given if pregnancy is
suspected or patient is in reproductive age group.
Preferred combination is a 2-drug combination
and EFV (600mg once daily) or Nelfinavir (NFV)
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 TABLE 1: Recommended schedule of investiga-
tions
 following exposure
   Period Recommended investigations




Pregnancy test if EFV is
considered
 Two weeks Full blood count
Liver function test
Renal function test
 Six weeks HIV screening
 Three months HIV screening
 Six months HIV screening
TABLE 2: Antiretroviral drugs for post- exposure prophylaxis










or 625mg                         Diarrhea, nausea,
                                         rash, exacerbation
                                         of chronic liver
















   Can be given with
   food
  Best given  with food
  (light meal or snack).
  Can be crushed and
  administered as
  powder, or dissolved
  in water.
HIV Occupational Exposure
1250mg bd or lopinavir/retonavir (LPV/
RTV)(400mg/100mg twice daily)
The chosen regimen is continued for 28 days
or until the result of HIV test for the patient and
exposed health worker is known to be negative.
[5,9]
Care of Site Contaminated with Potentially
HIV- Infected Body Fluid
In the event of an injury with a sharp object such
as a needle or scalpel that has been used on a patient
or in the event of a mucous membrane surface
contaminated with blood or secretions from a
patient, the following steps  should be followed:
• Allow blood to flow freely from wound if
bleeding.
• Wash exposed area thoroughly with soap
and water but without scrubbing.
• Rinse eye or mouth with plenty of water if
contaminated.
• Report the injury immediately to a senior
member of staff, supervisor or the post -
exposure prophylaxis designated officer of
the unit.
• Take antiretroviral drugs recommended for
post-exposure prophylaxis immediately- this
should be started within one hour if possible
and at the latest within 72 hours of the
exposure. Persons presenting after 72 hours
should also be considered for post-exposure
prophylaxis.
• Ascertain the HIV status of the patient and
the exposed health worker after providing
appropriate pretest counseling- the standard
rapid HIV antibody test that are currently
used in the voluntary counseling and testing
programme should be used and the result
of the tests obtained as quickly as possible.
[5,6]
The Source Patient
If initial assessment suggests a  potential for HIV
infection, consideration must be given to the HIV
status of the source patient. This should be done
with the source patient’s consent. Adequate pre-
test counseling must be done by trained counselors.
If the source patient is newly diagnosed HIV positive
as a result of this process, he/she will need immedi-
ate access to specialist post-test counseling and as-
surance about confidentiality. Close support and clini-
cal management will be needed on an ongoing ba-
sis. The source patient should also be informed
promptly of HIV negative results with any post- test
counseling appropriate to individual circumstances.
[3]
The Unknown Source
If there is significant exposure and a source patient
cannot be identified, risk assessment should be on
individual basis. This will be informed by a
consideration of the circumstances of the exposure,
and the epidemiological likelihood of HIV in the
source. In the vast majority of such exposures, it
wound be difficult to justify the use of PEP. [3]
Use of Antiretroviral Therapy Following
Exposure to Potentially Infectious Body Fluids
Depending on the result of the HIV test, the following
action should be taken:
If the source patient is HIV negative:
• No further post-exposure prophylaxis is
required for the exposed health worker.
If the exposed health worker is HIV positive:
• No further post-exposure prophylaxis is
necessary. The health worker should be
referred for further counseling and
management on a long term basis.
If the health worker is HIV negative and the
source patient is HIV positive:
• Continue antiretroviral for a period of four
weeks;
• Repeat health worker’s  HIV test at 3
months and 6 months  after the initial test.
• Should the health worker seroconvert during
this period then provide adequate care and
counseling and refer for expert opinion and
long term management
If it is not possible to determine the HIV status
of the source patient:
• Assume that the source patient is positive
and proceed according to guideline above
[5,6]





Resistance should be suspected if there has been
prolonged treatment with any antiretroviral agent,
where there is clinical progression of disease or a
persistently increasing viral load and or a decline in
CD4 lymphocyte despite therapy, or a lack of
virological response to a change in therapy.
Antiretroviral drug resistance profiling where
available should be taken into account when selecting
PEP drugs. Specialist advice should be sought.
Laboratory staff
Similarly, in the case of laboratory based staff,
knowledge about the source virus may be very
important. This would be the case, particularly,  if a
virus with multiple nucleoside analogue resistance
and or protease inhibitor resistance is  being handled.
Pregnancy
Pregnancy does not preclude the use of PEP.  Expert
advice should always be sought if PEP is considered
indicated for a female health care worker who is
pregnant, after assessment of the circumstances of
the exposure and of the source patient. Urgent
pregnancy testing should be arranged for any female
worker who cannot rule out the possibility of
pregnancy, as part of the evaluation prior to the
exposed worker reaching a personal, informed
decision about starting PEP. A pregnant health care
worker who has experienced an occupational HIV
exposure should be counseled about the risk of HIV
infection, about the risk of transmission to her baby,
and about everything that is known and not known
about the potential benefits and risks of antiretroviral
therapy for her and her baby, to help her reach an
informed personal decision about the use of PEP.
[3,10]
CONCLUSION AND RECOMMENDATION
Health care workers should observe universal
precaution in the workplace so as to reduce to the
barest minimum the possibility of injury. They should
be informed and educated about the possible risks
from occupational exposure and should be aware
of the importance of seeking urgent advice following
any needle stick injury or other occupational
exposure. Regular training should ensure that
everyone knows whom to report. Health workers
who are occupationally exposed to HIV must have
immediate access to PEP. The risk of HIV
transmission through the route of injury sustained
must be assessed and adequate management given.
Post-exposure prophylaxis (PEP) should be
commenced within an hour of exposure and should
last four weeks to reduce risk of HIV
seroconversion. All health workers who report
exposure to HIV at work whether given PEP or not
should be followed up for six months before a
negative antibody test is used to reassure the
individual that infection has not occurred.
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